X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (31) 31
tuberculosis (29) 29
humans (26) 26
infectious diseases (19) 19
medical and health sciences (17) 17
medicin och hälsovetenskap (17) 17
female (16) 16
microbiology (16) 16
male (15) 15
adult (12) 12
diagnosis (11) 11
middle aged (11) 11
mycobacterium tuberculosis - isolation & purification (11) 11
respiratory system (11) 11
adolescent (10) 10
aged (9) 9
basic medicine (8) 8
drug resistance (8) 8
immunology (8) 8
medicine (8) 8
medicinska och farmaceutiska grundvetenskaper (8) 8
mycobacterium-tuberculosis (8) 8
epidemiology (7) 7
infection (7) 7
risk factors (7) 7
tuberculosis - diagnosis (7) 7
analysis (6) 6
antitubercular agents - therapeutic use (6) 6
disease (6) 6
ethiopia - epidemiology (6) 6
hiv infections - complications (6) 6
mdr-tb (6) 6
mycobacterium tuberculosis - genetics (6) 6
patients (6) 6
pharmacokinetics (6) 6
public health (6) 6
research article (6) 6
rifampin (6) 6
science (6) 6
tuberculosis - epidemiology (6) 6
farmakologi och toxikologi (5) 5
health aspects (5) 5
hiv infections - epidemiology (5) 5
hospitals (5) 5
human-immunodeficiency-virus (5) 5
molecular epidemiology (5) 5
moxifloxacin (5) 5
multidisciplinary sciences (5) 5
mycobacterium tuberculosis (5) 5
pharmacology and toxicology (5) 5
prevalence (5) 5
pulmonary tuberculosis (5) 5
active tuberculosis (4) 4
bacterial diseases (4) 4
bacterial infections and mycoses (4) 4
clinical medicine (4) 4
clinical pharmacology (4) 4
cohort studies (4) 4
delamanid (4) 4
disease control (4) 4
drug resistance, bacterial - genetics (4) 4
ethiopia (4) 4
farmaceutiska vetenskaper (4) 4
infections (4) 4
isoniazid (4) 4
klinisk medicin (4) 4
laboratories (4) 4
latent tuberculosis (4) 4
pharmaceutical sciences (4) 4
research (4) 4
sensitivity and specificity (4) 4
sputum (4) 4
sweden - epidemiology (4) 4
treatment outcome (4) 4
tuberculin test (4) 4
tuberculosis - drug therapy (4) 4
tuberculosis - immunology (4) 4
tuberculosis, multidrug-resistant - drug therapy (4) 4
tuberculosis, pulmonary - complications (4) 4
tuberculosis, pulmonary - epidemiology (4) 4
young adult (4) 4
aids-related opportunistic infections - complications (3) 3
aids-related opportunistic infections - epidemiology (3) 3
algorithms (3) 3
antigens (3) 3
antitubercular agents - pharmacology (3) 3
bacteria (3) 3
care and treatment (3) 3
child (3) 3
child, preschool (3) 3
china (3) 3
drug therapy (3) 3
drug-resistant tuberculosis (3) 3
drugs (3) 3
education (3) 3
extensively drug-resistant tuberculosis - drug therapy (3) 3
gamma release assays (3) 3
genetic aspects (3) 3
genotype (3) 3
hiv (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The European respiratory journal, 12/2019
Studies investigating the risk of active tuberculosis (TB) in association with pregnancy have not been conclusive. We aimed at investigating this risk in a... 
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 2014, Volume 190, Issue 10, pp. 1168 - 1176
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1212 - 1217
Objective To estimate the risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) both with and without exposure to biological therapy and to... 
SWEDEN | REGISTER | Rheumatoid Arthritis | SERIOUS INFECTION | Anti-TNF | MONOCLONAL-ANTIBODY | NECROSIS-FACTOR ANTAGONISTS | RHEUMATOLOGY | FACTOR THERAPY | Tuberculosis | Treatment | DISEASES | BRITISH-SOCIETY | AGENTS | INFLIXIMAB | Tuberculosis - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Middle Aged | Risk Factors | Arthritis, Rheumatoid - epidemiology | Proportional Hazards Models | Immunoglobulin G - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Sweden - epidemiology | Case-Control Studies | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Adult | Female | Aged | Adalimumab | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Cohort Studies | Complications and side effects | Care and treatment | Usage | Biological products | Rheumatoid arthritis | Health aspects | Risk factors | Drugs | Disease | Laboratories | Bias | Rheumatology | Personal identification numbers | Estimates | Studies | Education | Immunotherapy | Quality | Rheumatism | Population | TNF inhibitors | Tumor necrosis factor-TNF | Chronic obstructive pulmonary disease | Basic Medicine | Immunologi inom det medicinska området | Medical and Health Sciences | Medicin och hälsovetenskap | Immunology in the medical area | Medicinska och farmaceutiska grundvetenskaper
Journal Article
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 05/2017, Volume 49, Issue 5, pp. 1700387 - 1700387
Journal Article
HEALTH AND QUALITY OF LIFE OUTCOMES, ISSN 1477-7525, 10/2019, Volume 17, Issue 1, pp. 1 - 7
Background Unlike active tuberculosis, latent tuberculosis infection (LTBI) is asymptomatic and often considered not to affect the health-related quality of... 
Mixed methods design | Health-related quality of life | Screening | HEALTH CARE SCIENCES & SERVICES | Latent tuberculosis | MIGRANTS | HEALTH POLICY & SERVICES | Migrant | HEALTH-STATUS
Journal Article
European Respiratory Journal, ISSN 0903-1936, 02/2019, Volume 53, Issue 2
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 04/2017, Volume 49, Issue 4, pp. 1700173 - 1700173
The new short-course World Health Organization (WHO)-endorsed regimen for multidrug-resistant (MDR) tuberculosis (TB) resistant to rifampicin and isoniazid... 
MOXIFLOXACIN | RESPIRATORY SYSTEM | MDR-TB | Fluoroquinolones | Tuberculosis | Drug resistance | Isoniazid | Rifampin
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e43438
Background: There is a need for reliable markers to diagnose active and latent tuberculosis (TB). The interferon gamma release assays (IGRAs) are compared to... 
SINGLE-CELL LEVEL | MYCOBACTERIUM-TUBERCULOSIS | WHOLE-BLOOD | CYTOKINE PROFILES | GAMMA-INDUCIBLE PROTEIN-10 | INTERFERON-GAMMA | ACTIVE TUBERCULOSIS | MULTIDISCIPLINARY SCIENCES | SKIN-TEST | FLOW-CYTOMETRY | T-CELLS | Lung - microbiology | Chemokine CXCL10 - blood | Humans | Middle Aged | Antigens, Bacterial - immunology | Mycobacterium tuberculosis - immunology | Male | Tuberculosis - microbiology | Tuberculosis - diagnosis | Mycobacterium tuberculosis - isolation & purification | Tuberculosis - immunology | Young Adult | Adolescent | Chemokine CXCL10 - immunology | Adult | Female | Aged | Bacterial Proteins - immunology | Tuberculosis - blood | Lung - immunology | Cytokines - blood | Cytokines - immunology | Antigens | Technology application | Tuberculosis | Immune response | Financial planners | Comparative analysis | Biological response modifiers | Interferon gamma | Multiplexing | Stimulation | Infections | Tuberculin | Medical diagnosis | Blood | Interleukin 6 | Proteins | Interleukin 4 | Interleukin 5 | Immunology | Interleukin 2 | Technology | Lymphocytes | IP-10 protein | Tumor necrosis factor-TNF | Diagnosis | Active control | Lymphoblasts | Cytokines | Granulocyte-macrophage colony-stimulating factor | Interleukin 12 | T cell receptors | Interleukin 13 | Tumor necrosis factor-α | Patients | Disease control | Interleukin 17 | Hospitals | ESAT-6 antigen | Infectious diseases | γ-Interferon | Interleukin 10 | Biomarkers | Interferon | Skin | Fascia | Chemokines | Skin tests
Journal Article
Journal Article
by Lönnroth, Knut and Migliori, Giovanni Battista and Abubakar, Ibrahim and D'Ambrosio, Lia and De Vries, Gerard and Diel, Roland and Douglas, Paul and Falzon, Dennis and Gaudreau, Marc-Andre and Goletti, Delia and González Ochoa, Edilberto R and LoBue, Philip and Matteelli, Alberto and Njoo, Howard and Solovic, Ivan and Story, Alistair and Tayeb, Tamara and Van Der Werf, Marieke J and Weil, Diana and Zellweger, Jean-Pierre and Aziz, Mohamed Abdel and Al Lawati, Mohamed R. M and Aliberti, Stefano and De Oñate, Wouter Arrazola and Barreira, Draurio and Bhatia, Vineet and Blasi, Francesco and Bloom, Amy and Bruchfeld, Judith and Castelli, Francesco and Centis, Rosella and Chemtob, Daniel and Cirillo, Daniela M and Colorado, Alberto and Dadu, Andrei and Dahle, Ulf R and De Paoli, Laura and Dias, Hannah M and Duarte, Raquel and Fattorini, Lanfranco and Gaga, Mina and Getahun, Haileyesus and Glaziou, Philippe and Goguadze, Lasha and Del Granado, Mirtha and Haas, Walter and Järvinen, Asko and Kwon, Geun-Yong and Mosca, Davide and Nahid, Payam and Nishikiori, Nobuyuki and Noguer, Isabel and O'Donnell, Joan and Pace-Asciak, Analita and Pompa, Maria G and Popescu, Gilda G and Cordeiro, Carlos Robalo and Rønning, Karin and Ruhwald, Morten and Sculier, Jean-Paul and Simunović, Aleksandar and Smith-Palmer, Alison and Sotgiu, Giovanni and Sulis, Giorgia and Torres-Duque, Carlos A and Umeki, Kazunori and Uplekar, Mukund and Van Weezenbeek, Catharina and Vasankari, Tuula and Vitillo, Robert J and Voniatis, Constantia and Wanlin, Maryse and Raviglione, Mario C
European Respiratory Journal, ISSN 0903-1936, 04/2015, Volume 45, Issue 4, pp. 928 - 952
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2017, Volume 12, Issue 11
Objective: Interferon gamma release assays like Quantiferon Gold In-Tube (QFT) are used to identify individuals infected with Mycobacterium tuberculosis. A... 
Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Infectious Medicine | Klinisk medicin
Journal Article
Cold Spring Harbor Perspectives in Medicine, ISSN 2157-1422, 07/2015, Volume 5, Issue 7, p. a017871
Journal Article